Samples were obtained from an efficacy trial of two pandemic influenza H1N1 vaccines (NCT01051661 sponsored by GSK Vaccines). 8 An analysis estimating the prevalence of RSV in ILI has been previously reported. 9 Here, we report data on all respiratory viruses evaluated, a secondary analysis objective. 